Your browser doesn't support javascript.
loading
Acute disseminated encephalomyelitis and routine childhood vaccinations - a self-controlled case series.
Martin, T J; Fahey, M; Easton, M; Clothier, H J; Samuel, R; Crawford, N W; Buttery, J P.
Afiliación
  • Martin TJ; Department of Paediatrics, Monash University, Clayton, Australia.
  • Fahey M; Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children's Research Institute (MCRI), Parkville, Australia.
  • Easton M; Department of General Medicine, Royal Children's Hospital (RCH), Parkville, Australia.
  • Clothier HJ; Department of Paediatrics, Monash Health, Clayton, Australia.
  • Samuel R; Department of Paediatrics, Monash University, Clayton, Australia.
  • Crawford NW; Department of Paediatrics, Monash Health, Clayton, Australia.
  • Buttery JP; Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children's Research Institute (MCRI), Parkville, Australia.
Hum Vaccin Immunother ; 17(8): 2578-2585, 2021 08 03.
Article en En | MEDLINE | ID: mdl-33835888
Acute disseminated encephalomyelitis (ADEM) is an autoimmune, central nervous system demyelinating disorder that follows antecedent immunologic challenges, such as infection or vaccination. This study aimed to investigate the potential association between routine childhood vaccinations and ADEM. Children under 7 years of age admitted to the two tertiary level pediatric hospitals in Victoria, Australia with ADEM from 2000-2015 had their clinical information linked to vaccination records from the Australian Childhood Immunization Register. Chart review was undertaken utilizing the Brighton Collaboration ADEM criteria. The self-controlled case-series (SCCS) methodology was employed to determine the relative incidences of ADEM post-vaccination in two risk intervals: 5-28 days and 2-42 days. Forty-six cases were eligible for SCCS analysis with a median age of 3.2 years. Of the forty-six cases, three were vaccine proximate cases and received vaccinations 23, 25 and 28 days before ADEM onset. Two vaccine proximate cases received their 4-year-old scheduled vaccinations (MMR and DTPa-IPV) and one vaccine proximate case the 1-year old scheduled vaccinations (MMR and Hib-MenC). The relative incidence of ADEM during the narrow and broad risk intervals were 1.041 (95% CI 0.323-3.356, p = 0.946) and 0.585 (95% CI 0.182-1.886, p = 0.370) respectively. Sensitivity analyses did not yield any substantial deviations. These results do not provide evidence of an association between vaccinations routinely provided to children aged under 7 years in Australia and the incidence of ADEM. However, these results should be interpreted with caution as the number of ADEM cases identified was limited and further research is warranted.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / Encefalomielitis Aguda Diseminada Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Child / Child, preschool / Humans / Infant País/Región como asunto: Oceania Idioma: En Revista: Hum Vaccin Immunother Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / Encefalomielitis Aguda Diseminada Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Child / Child, preschool / Humans / Infant País/Región como asunto: Oceania Idioma: En Revista: Hum Vaccin Immunother Año: 2021 Tipo del documento: Article País de afiliación: Australia